Table 2 Quantitative and qualitative computed tomography (CT) findings related to COVID-19, and secondary CT findings
Volume of disease (cm3; median, range) | 249.5 (9.9–1505) |
|---|---|
Uni/bilateral | |
Unilateral | 7/106 (6.6%) |
Bilateral | 99/106 (93.4%) |
Affected lobes | |
Only lower lobe(s) | 5/106 (4.7%) |
Lower lobe(s) + at least one other lobe | 97/106 (91.5%) |
No lower lobe involvement | 4/106 (3.8%) |
Gradient | |
Apicobasal gradient | 49/106 (46.2%) |
No apicobasal gradient | 57/106 (53.8%) |
Distribution | |
Peripheral | 39/106 (36.8%) |
Central | 2/106 (1.9%) |
Mixed | 65/106 (61.3%) |
CT pattern | |
Pure GGO | 11/106 (10.4%) |
GGO + septal thickening | 46/106 (43.4%) |
GGO + consolidation | 49/106 (46.2%) |
Predominant type | |
GGO | 79/106 (74.5%) |
Consolidation | 27/106 (25.5%) |
CT sign | |
Reverse halo | 7/106 (6.6%) |
Linear opacities | 66/106 (62.3%) |
Nodules | 28/106 (26.4%) |
Secondary findings | |
Emphysema | 13/106 (12.3%) |
Fibrosis | 8/106 (7.5%) |
Enlarged lymph nodes (≥ 10 mm short axis) | 33/106 (31.1%) |
Pleural effusion | 10/106 (9.4%) |
Pleural thickening | 15/106 (14.15%) |
Aortic Calcification | 45/106 (42.5%) |
Coronary calcification | 53/106 (50.0%) |
Other | |
Pneumomediastinum | 1/106 (0.9%) |
Iatrogenic pneumothorax and subcutaneous emphysema | 1/106 (0.9%) |